Morrow T, Felcone LH. Defining the difference: what makes biologics unique. Biotechnol Healthc. 2004;1(4):24–9.

PubMed  PubMed Central  Google Scholar 

Balocco R, De Sousa Guimaraes Koch S, Thorpe R, Weisser K, Malan S. New INN nomenclature for monoclonal antibodies. Lancet. 2022;399(10319):24. https://doi.org/10.1016/S0140-6736(21)02732-X.

WHO. New INN nomenclature scheme for monoclonal antibodies. Geneva: World Heal Org. 2022.

WHO. Nomenclature for monoclonal antibodies. Geneva: World Heal Org. 2009.

Awad RM, Meeus F, Ceuppens H, Ertveldt T, Hanssens H, Lecocq Q, et al. Emerging applications of nanobodies in cancer therapy. Int Rev Cell Mol Biol. 2022;369:143–99. https://doi.org/10.1016/bs.ircmb.2022.03.010.

Article  PubMed  Google Scholar 

Xu S, Yang K, Li R, Zhang L. mRNA Vaccine era-mechanisms, drug platform and clinical prospection. Int J Mol Sci. 2020;21(18). https://doi.org/10.3390/ijms21186582.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15. https://doi.org/10.1056/NEJMoa2034577.

Article  PubMed  CAS  Google Scholar 

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16. https://doi.org/10.1056/NEJMoa2035389.

Article  PubMed  CAS  Google Scholar 

Maggi E, Vultaggio A, Matucci A. Acute infusion reactions induced by monoclonal antibody therapy. Expert Rev Clin Immunol. 2011;7(1):55–63. https://doi.org/10.1586/eci.10.90.

Article  PubMed  CAS  Google Scholar 

Caiado J, Castells MC. Drug desensitizations for chemotherapy: safety and efficacy in preventing anaphylaxis. Curr Allergy Asthma Rep. 2021;21(6):37. https://doi.org/10.1007/s11882-021-01014-x.

Article  PubMed  CAS  Google Scholar 

•• Yang BC, Castells MC. The who, what, where, when, why, and how of drug desensitization. immunology and allergy clinics of North America. 2022. https://doi.org/10.1016/j.iac.2021.12.004. Thorough guide on the pathophysiologic mechanisms of rapid drug desensitization and how to perform desensitization.

Yang BC, Castells MC. Rituximab hypersensitivity and desensitization: a personalized approach to treat cancer and connective tissue diseases. Ann Allergy Asthma Immunol. 2019;123(1):11–5. https://doi.org/10.1016/j.anai.2019.03.008.

Article  PubMed  Google Scholar 

Yang BC, Castells M. Diagnosis and treatment of drug hypersensitivity reactions to biologicals: medical algorithm. Allergy. 2020. https://doi.org/10.1111/all.14432.

Article  PubMed  Google Scholar 

Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371–6. https://doi.org/10.1016/j.jaci.2004.04.029.

Article  PubMed  Google Scholar 

Picard M, Pur L, Caiado J, Giavina-Bianchi P, Galvao VR, Berlin ST, et al. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions. J Allergy Clin Immunol. 2016;137(4):1154–64 e12. https://doi.org/10.1016/j.jaci.2015.10.039.

Madrigal-Burgaleta R, Bernal-Rubio L, Berges-Gimeno MP, Carpio-Escalona LV, Gehlhaar P, Alvarez-Cuesta E. A large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents. J Allergy Clin Immunol Pract. 2019;7(2):618–32. https://doi.org/10.1016/j.jaip.2018.07.031.

Article  PubMed  Google Scholar 

Madrigal-Burgaleta R, Vazquez-Revuelta P, Marti-Garrido J, Lleonart R, Ali FR, Alvarez-Cuesta E. Importance of diagnostics prior to desensitization in new drug hypersensitivity: chemotherapeutics and biologicals. Current Treatment Options in Allergy. 2020;7(1):1–13. https://doi.org/10.1007/s40521-020-00238-y.

Article  Google Scholar 

Castells M. Drug hypersensitivity and anaphylaxis in cancer and chronic inflammatory diseases: the role of desensitizations. Front Immunol. 2017;8:1472. https://doi.org/10.3389/fimmu.2017.01472.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122(3):574–80. https://doi.org/10.1016/j.jaci.2008.02.044.

Article  PubMed  CAS  Google Scholar 

Hsu Blatman KS, Castells MC. Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes. Curr Allergy Asthma Rep. 2014;14(8):453. https://doi.org/10.1007/s11882-014-0453-5.

Article  PubMed  CAS  Google Scholar 

Hong DI, Dioun AF. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children. J Allergy Clin Immunol Pract. 2014;2(1):13–9; quiz 20. https://doi.org/10.1016/j.jaip.2013.11.007.

Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol. 2009;124(6):1259–66. https://doi.org/10.1016/j.jaci.2009.09.009.

Article  PubMed  CAS  Google Scholar 

Castells M. Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol. 2017;140(2):321–33. https://doi.org/10.1016/j.jaci.2017.06.012.

Article  PubMed  Google Scholar 

Picard M, Galvao VR. Current knowledge and management of hypersensitivity reactions to monoclonal antibodies. J Allergy Clin Immunol Pract. 2017;5(3):600–9. https://doi.org/10.1016/j.jaip.2016.12.001.

Article  PubMed  Google Scholar 

Isabwe GAC, Garcia Neuer M, de Las Vecillas Sanchez L, Lynch DM, Marquis K, Castells M. Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes. J Allergy Clin Immunol. 2018;142(1):159–70 e2. https://doi.org/10.1016/j.jaci.2018.02.018.

Vitte J, Sabato V, Tacquard C, Garvey LH, Michel M, Mertes PM, et al. Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis. J Allergy Clin Immunol Pract. 2021;9(8):2994–3005. https://doi.org/10.1016/j.jaip.2021.03.011.

Article  PubMed  CAS  Google Scholar 

Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564–9. https://doi.org/10.1038/ng.3696.

Article  PubMed  PubMed Central  CAS  Google Scholar 

• Giannetti MP, Weller E, Bormans C, Novak P, Hamilton MJ, Castells M. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis. Ann Allergy Asthma Immunol. 2021;126(6):655–60. https://doi.org/10.1016/j.anai.2021.01.016. Excellent evidence for maintaining suspicion for hereditary alpha-tryptasemia in patients with anaphylaxis.

Article  PubMed  CAS  Google Scholar 

Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008;358(11):1109–17. https://doi.org/10.1056/NEJMoa074943.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chinuki Y, Morita E. Alpha-Gal-containing biologics and anaphylaxis. Allergol Int. 2019;68(3):296–300. https://doi.org/10.1016/j.alit.2019.04.001.

Article  PubMed  CAS  Google Scholar 

Campos L, Galvao VR, Kalil J, Castells M, Giavina-Bianchi P. BAT in the diagnosis of drug allergy: a novel tool in clinical daily practice? Curr Allergy Asthma Rep. 2019;19(4):20. https://doi.org/10.1007/s11882-019-0852-8.

Article  PubMed  Google Scholar 

Piva E, Chieco-Bianchi F, Krajcar V, Aversa S, Plebani M. Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: in vitro evaluation of rituximab hypersensitivity by basophil activation test. Am J Hematol. 2012;87(11):E130–1. https://doi.org/10.1002/ajh.23329.

Article  PubMed  CAS  Google Scholar 

Thevenot J, Ferrier le Bouedec MC, Buisson A, Bommelaer G, D'Incan M, Rouzaire P. Rapid desensitization to adalimumab is associated with decreased basophil sensitivity. J Investig Allergol Clin Immunol. 2019;29(2):141–3. https://doi.org/10.18176/jiaci.0350.

de la Varga MR, Gutierrez Fernandez D, Foncubierta Fernandez A, Andres Garcia JA, Medina VF. Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test. Allergol Int. 2017;66(2):357–9. https://doi.org/10.1016/j.alit.2016.09.002.

Article  Google Scholar 

Gonzalez-de-Olano D, Morgado JM, Juarez-Guerrero R, Sanchez-Munoz L, Letellez-Fernandez J, Malon-Gimenez D, et al. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization. J Allergy Clin Immunol Pract. 2016;4(2):338–40. https://doi.org/10.1016/j.jaip.2015.10.007.

Article  PubMed  Google Scholar 

Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59(8):809–20. https://doi.org/10.1111/j.1398-9995.2004.00547.x.

Article  PubMed  CAS  Google Scholar 

Giraldo-Tugores M, Fernandez-Lozano C, Carron-Herrero A, Gajate P, Martinez-Botas J, Pueyo-Lopez C, et al. Successful rapid desensitization to atezolizumab in delayed hypersensitivity confirmed with lymphocyte transformation test. J Allergy Clin Immunol Pract. 2022. https://doi.org/10.1016/j.jaip.2021.12.041.

Article  PubMed  Google Scholar 

Jakubovic BD, Sanchez-Sanchez S, Hamadi S, Lynch DM, Castells M. Interleukin-6: a novel biomarker for monoclonal antibody and chemotherapy-associated hypersensitivity confirms a cytokine release syndrome phenotype-endotype association. Allergy. 2020. https://doi.org/10.1111/all.14644.

Article  PubMed  Google Scholar 

Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398–405. https://doi.org/10.1016/j.vaccine.2015.07.035.

Article  PubMed  PubMed Central  Google Scholar 

Blumenthal KG, Robinson LB, Camargo CA Jr, Shenoy ES, Banerji A, Landman AB, et al. Acute allergic reactions to mRNA COVID-19 vaccines. JAMA. 2021;325(15):1562–5. https://doi.org/10.1001/jama.2021.3976.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tanno LK, Castells M, Caminati M, Senna G, Demoly P. Anaphylaxis and coronavirus disease 2019 vaccine: a danger relationship? Curr Opin Allergy Clin Immunol. 2021;21(5):411–7. https://doi.org/10.1097/ACI.0000000000000778.

Article  PubMed  CAS  Google Scholar 

Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016;9(1):32. https://doi.org/10.1186/s40413-016-0120-5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med. 2021;384(7):643–9. https://doi.org/10.1056/NEJMra2035343.